Estradiol and neurodegenerative oxidative stress
暂无分享,去创建一个
[1] R. Irwin,et al. Estrogen protects neuronal cells from amyloid beta-induced apoptosis via regulation of mitochondrial proteins and function , 2006, BMC Neuroscience.
[2] Yaxuan Sun,et al. Cu(II) potentiation of Alzheimer Abeta1-40 cytotoxicity and transition on its secondary structure. , 2006, Acta biochimica et biophysica Sinica.
[3] R. Brinton,et al. Dose and temporal pattern of estrogen exposure determines neuroprotective outcome in hippocampal neurons: therapeutic implications. , 2006, Endocrinology.
[4] J. Ávila,et al. Estradiol Prevents Neural Tau Hyperphosphorylation Characteristic of Alzheimer's Disease , 2005, Annals of the New York Academy of Sciences.
[5] G. Perry,et al. Therapeutic opportunities in Alzheimer disease: one for all or all for one? , 2005, Current medicinal chemistry.
[6] C. Masters,et al. Copper-Dependent Inhibition of Human Cytochrome c Oxidase by a Dimeric Conformer of Amyloid-β1-42 , 2005, The Journal of Neuroscience.
[7] G. Drewes. MARKing tau for tangles and toxicity. , 2004, Trends in biochemical sciences.
[8] R. Brinton,et al. Mitochondria as therapeutic targets of estrogen action in the central nervous system. , 2004, Current drug targets. CNS and neurological disorders.
[9] S. Shumaker,et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. , 2004, JAMA.
[10] Roberta Diaz Brinton,et al. Estrogen receptor subtypes alpha and beta contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons , 2004, Brain Research.
[11] J. Simpkins,et al. Transient Cerebral Ischemia Induces Aberrant Neuronal Cell Cycle Re-entry and Alzheimer's Disease-like Tauopathy in Female Rats* , 2004, Journal of Biological Chemistry.
[12] Dick F. Swaab,et al. Colocalization and alteration of estrogen receptor-α and -β in the hippocampus in Alzheimer’s disease , 2004 .
[13] G. Audesirk,et al. β-estradiol influences differentiation of hippocampal neurons in vitro through an estrogen receptor-mediated process , 2003, Neuroscience.
[14] R. Ravid,et al. Estrogen receptor α-immunoreactive astrocytes are increased in the hippocampus in Alzheimer’s disease , 2003, Experimental Neurology.
[15] D. Sparks,et al. Trace amounts of copper in water induce β-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[16] R. Ravid,et al. Decreased estrogen receptor-α expression in hippocampal neurons in relation to hyperphosphorylated tau in Alzheimer patients , 2003, Acta Neuropathologica.
[17] Kazuyuki Takata,et al. Cdk5 Is a Key Factor in Tau Aggregation and Tangle Formation In Vivo , 2003, Neuron.
[18] J. Sweatt,et al. Mitochondrial Regulation of Synaptic Plasticity in the Hippocampus* , 2003, The Journal of Biological Chemistry.
[19] D. Pfaff,et al. Immunolocalization of estrogen receptor β in the mouse brain: Comparison with estrogen receptor α , 2003 .
[20] B. Sherwin,et al. Estrogen and cognitive functioning in women. , 2003, Endocrine reviews.
[21] G. Perry,et al. Effect of the lipid peroxidation product acrolein on tau phosphorylation in neural cells , 2003, Journal of neuroscience research.
[22] R. Maccioni,et al. Iron-induced oxidative stress modify tau phosphorylation patterns in hippocampal cell cultures , 2003, Biometals.
[23] J. Sastre,et al. Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males. , 2003, Free radical biology & medicine.
[24] Roberta Diaz Brinton,et al. Mechanism of estrogen-mediated neuroprotection: Regulation of mitochondrial calcium and Bcl-2 expression , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[25] S. Goodenough,et al. Estrogen-induced cell signalling in a cellular model of Alzheimer’s disease , 2003, The Journal of Steroid Biochemistry and Molecular Biology.
[26] T. Horvath,et al. Estrogen, synaptic plasticity and hypothalamic reproductive aging , 2003, Experimental Gerontology.
[27] H. Fillit,et al. Tau and Alzheimer’s disease , 2002, Journal of Molecular Neuroscience.
[28] P. Zandi,et al. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. , 2002, JAMA.
[29] D. Swaab,et al. Increased p75NTR Expression in Hippocampal Neurons Containing Hyperphosphorylated τ in Alzheimer Patients , 2002, Experimental Neurology.
[30] I. Grundke‐Iqbal,et al. Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK‐3β , 2002, FEBS letters.
[31] M. Brockhaus,et al. The effects of β-estradiol on SHSY5Y neuroblastoma cells during heavy metal induced oxidative stress, neurotoxicity and β-amyloid secretion , 2002, Neuroscience.
[32] D. Butterfield,et al. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase‐related protein 2, α‐enolase and heat shock cognate 71 , 2002, Journal of neurochemistry.
[33] Todd B. Sherer,et al. An In Vitro Model of Parkinson's Disease: Linking Mitochondrial Impairment to Altered α-Synuclein Metabolism and Oxidative Damage , 2002, The Journal of Neuroscience.
[34] Lixia Zhao,et al. Neuroprotective and Neurotrophic Efficacy of Phytoestrogens in Cultured Hippocampal Neurons , 2002, Experimental biology and medicine.
[35] K. Davies,et al. Protein turnover by the proteasome in aging and disease. , 2002, Free radical biology & medicine.
[36] C. Lauderback,et al. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: Potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress , 2002 .
[37] G. Perry,et al. Amyloid-β, tau alterations and mitochondrial dysfunction in Alzheimer disease: the chickens or the eggs? , 2002, Neurochemistry International.
[38] Roberta Diaz Brinton,et al. Dual action of estrogen on glutamate-induced calcium signaling: mechanisms requiring interaction between estrogen receptors and src/mitogen activated protein kinase pathway , 2002, Brain Research.
[39] D. Price,et al. High Molecular Weight Neurofilament Proteins Are Physiological Substrates of Adduction by the Lipid Peroxidation Product Hydroxynonenal* , 2002, The Journal of Biological Chemistry.
[40] H. Vinters,et al. The Role of Oxidative Stress in the Pathophysiology of Cerebrovascular Lesions in Alzheimer's Disease , 2002, Brain pathology.
[41] J. Land,et al. β‐Amyloid inhibits integrated mitochondrial respiration and key enzyme activities , 2001, Journal of neurochemistry.
[42] C. Pike,et al. Estrogen modulates neuronal Bcl-xL expression and beta-amyloid-induced apoptosis: relevance to Alzheimer's disease. , 2001, Journal of neurochemistry.
[43] P. Wise,et al. Estradiol is a protective factor in the adult and aging brain: understanding of mechanisms derived from in vivo and in vitro studies , 2001, Brain Research Reviews.
[44] R. Ravid,et al. Hippocampal estrogen β-receptor immunoreactivity is increased in Alzheimer’s disease , 2001, Brain Research.
[45] V. Calabrese,et al. Mitochondrial Involvement in Brain Function and Dysfunction: Relevance to Aging, Neurodegenerative Disorders and Longevity , 2001, Neurochemical Research.
[46] R. Curi,et al. Regulation of antioxidant enzyme activities in male and female rat macrophages by sex steroids. , 2001, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[47] J. Simpkins,et al. Estradiol protects against ATP depletion, mitochondrial membrane potential decline and the generation of reactive oxygen species induced by 3‐nitroproprionic acid in SK‐N‐SH human neuroblastoma cells , 2001, Journal of neurochemistry.
[48] A. Deckel. Nitric oxide and nitric oxide synthase in Huntington's disease , 2001, Journal of neuroscience research.
[49] I. Mook‐Jung,et al. Neuroprotective effects of estrogen against beta-amyloid toxicity are mediated by estrogen receptors in cultured neuronal cells , 2001, Neuroscience Letters.
[50] B. McEwen,et al. Effects of estrogen deficiency on brain function. Implications for the treatment of postmenopausal women. , 2001, Postgraduate medicine.
[51] W. Markesbery,et al. Acrolein is increased in Alzheimer’s disease brain and is toxic to primary hippocampal cultures , 2001, Neurobiology of Aging.
[52] M. Kindy,et al. Estrogen receptor α, not β, is a critical link in estradiol-mediated protection against brain injury , 2001 .
[53] J. Parks,et al. Neurotoxic Aβ peptides increase oxidative stress in vivo through NMDA‐receptor and nitric‐oxide‐synthase mechanisms, and inhibit complex IV activity and induce a mitochondrial permeability transition in vitro , 2001, Journal of neurochemistry.
[54] E. Cadenas,et al. Mitochondrial respiratory chain-dependent generation of superoxide anion and its release into the intermembrane space. , 2001, The Biochemical journal.
[55] B. McEwen,et al. Ultrastructural evidence that hippocampal alpha estrogen receptors are located at extranuclear sites , 2001 .
[56] G. Perry,et al. Phosphorylated, but not native, tau protein assembles following reaction with the lipid peroxidation product, 4‐hydroxy‐2‐nonenal , 2000, FEBS letters.
[57] J. Kuret,et al. Oxidative regulation of fatty acid-induced tau polymerization. , 2000, Biochemistry.
[58] J W Yates,et al. Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. , 2000, Chemistry & biology.
[59] K. Ley,et al. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase , 2000, Nature.
[60] I. Merchenthaler,et al. Evidence for novel estrogen binding sites in the rat hippocampus , 2000, Neuroscience.
[61] K. Davies,et al. Mitochondrial free radical generation, oxidative stress, and aging. , 2000, Free radical biology & medicine.
[62] J. Simpkins,et al. Neuroprotective effects of estrogens: potential mechanisms of action , 2000, International Journal of Developmental Neuroscience.
[63] R. Brinton,et al. The women’s health initiative estrogen replacement therapy is neurotrophic and neuroprotective , 2000, Neurobiology of Aging.
[64] S. Rajaratnam,et al. An approach to postmenopausal osteoporosis. , 2000, National Medical Journal of India.
[65] J. Blass,et al. Inherent Abnormalities in Energy Metabolism in Alzheimer Disease: Interaction with Cerebrovascular Compromise , 2000, Annals of the New York Academy of Sciences.
[66] G. Mor,et al. Estrogen-regulated developmental neuronal apoptosis is determined by estrogen receptor subtype and the Fas/Fas ligand system. , 2000, Journal of neurobiology.
[67] Anthony Gamst,et al. Estrogen Replacement Therapy for Treatment of Mild to Moderate Alzheimer Disease: A Randomized Controlled Trial , 2000 .
[68] I. Merchenthaler,et al. Estrogen binding and estrogen receptor characterization (ERα and ERβ) in the cholinergic neurons of the rat basal forebrain , 2000, Neuroscience.
[69] M. Murakoshi,et al. Regulation of prostatic glutathione-peroxidase (GSH-PO) in rats treated with a combination of testosterone and 17 beta-estradiol. , 1999, The Journal of toxicological sciences.
[70] B. Paquette,et al. DNA damage induced by catecholestrogens in the presence of copper (II): generation of reactive oxygen species and enhancement by NADH. , 1999, Free radical biology & medicine.
[71] F. Holsboer,et al. The female sex hormone oestrogen as a neuroprotectant. , 1999, Trends in pharmacological sciences.
[72] T. Bates,et al. β‐Amyloid fragment 25–35 selectively decreases complex IV activity in isolated mitochondria , 1999, FEBS letters.
[73] P. Shughrue,et al. Estradiol Modulates bcl-2 in Cerebral Ischemia: A Potential Role for Estrogen Receptors , 1999, The Journal of Neuroscience.
[74] A. Delacourte. Biochemical and Molecular Characterization of Neurofibrillary Degeneration in Frontotemporal Dementias , 1999, Dementia and Geriatric Cognitive Disorders.
[75] J. York,et al. Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[76] Meharvan Singh,et al. Novel Mechanisms of Estrogen Action in the Brain: New Players in an Old Story , 1999, Frontiers in Neuroendocrinology.
[77] D. Dorsa,et al. The Mitogen-Activated Protein Kinase Pathway Mediates Estrogen Neuroprotection after Glutamate Toxicity in Primary Cortical Neurons , 1999, The Journal of Neuroscience.
[78] Xiaoping Guan,et al. Estrogen-Induced Activation of Mitogen-Activated Protein Kinase in Cerebral Cortical Explants: Convergence of Estrogen and Neurotrophin Signaling Pathways , 1999, The Journal of Neuroscience.
[79] D. Roy,et al. Concentration dependence of prooxidant and antioxidant properties of catecholestrogens. , 1998, Archives of biochemistry and biophysics.
[80] E. Mandelkow,et al. Overexpression of Tau Protein Inhibits Kinesin-dependent Trafficking of Vesicles, Mitochondria, and Endoplasmic Reticulum: Implications for Alzheimer's Disease , 1998, The Journal of cell biology.
[81] S. Finklestein,et al. Estradiol Protects against Ischemic Injury , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[82] M. Beal,et al. Mitochondrial dysfunction in neurodegenerative diseases. , 1998, Biochimica et biophysica acta.
[83] D. Dorsa,et al. Modulation of Bcl‐2 expression: a potential component of estrogen protection in NT2 neurons , 1998, Neuroreport.
[84] T. Arendt,et al. The use of okadaic acid in vivo and the induction of molecular changes typical for Alzheimer's disease , 1998, Neuroscience.
[85] J. Weisz,et al. Induction of nuclear catechol-O-methyltransferase by estrogens in hamster kidney: implications for estrogen-induced renal cancer. , 1998, Carcinogenesis.
[86] A. Day,et al. Testosterone increases and estradiol decreases middle cerebral artery occlusion lesion size in male rats , 1998, Brain Research.
[87] A. Conney,et al. Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis? , 1998, Cancer research.
[88] G. Mor,et al. Raloxifene Induces Neurite Outgrowth in, Estrogen Receptor Positive PC 12 Cells , 1998, Menopause.
[89] K. Imahori,et al. Characterization of tau phosphorylation in glycogen synthase kinase-3beta and cyclin dependent kinase-5 activator (p23) transfected cells. , 1998, Biochimica et biophysica acta.
[90] L. Amaducci,et al. Estrogen-replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging , 1998, Neurology.
[91] K. Yaffe,et al. Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. , 1998, JAMA.
[92] J. Simpkins,et al. Nuclear estrogen receptor-independent neuroprotection by estratrienes: a novel interaction with glutathione , 1998, Neuroscience.
[93] M. Mattson,et al. Estrogens stabilize mitochondrial function and protect neural cells against the pro-apoptotic action of mutant presenilin-1. , 1997, Neuroreport.
[94] M. Mattson,et al. 17β‐Estradiol attenuates oxidative impairment of synaptic Na+/K+‐ATPase activity, glucose transport, and glutamate transport induced by amyloid β‐peptide and iron , 1997, Journal of neuroscience research.
[95] R. Brinton,et al. 17 β-Estradiol Enhances the Outgrowth and Survival of Neocortical Neurons in Culture , 1997, Neurochemical Research.
[96] J. Simpkins,et al. Phenolic A ring requirement for the neuroprotective effects of steroids , 1997, The Journal of Steroid Biochemistry and Molecular Biology.
[97] K. Korach,et al. Tissue Distribution and Quantitative Analysis of Estrogen Receptor-α (ERα) and Estrogen Receptor-β (ERβ) Messenger Ribonucleic Acid in the Wild-Type and ERα-Knockout Mouse. , 1997, Endocrinology.
[98] K. Patil,et al. Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[99] S. Kato,et al. Rapid activation of MAP kinase by estrogen in the bone cell line. , 1997, Biochemical and biophysical research communications.
[100] R. Brookmeyer,et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease , 1997, Neurology.
[101] V. Henderson. The epidemiology of estrogen replacement therapy and Alzheimer's disease , 1997, Neurology.
[102] F. Holsboer,et al. Neuroprotection against oxidative stress by estrogens: structure-activity relationship. , 1997, Molecular pharmacology.
[103] D. Hanger,et al. Oxidative Stress Induces Dephosphorylation of τ in Rat Brain Primary Neuronal Cultures , 1997 .
[104] J. Liehr,et al. Dual role of oestrogens as hormones and pro-carcinogens: tumour initiation by metabolic activation of oestrogens. , 1997, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[105] S. Budd,et al. Mitochondria, Calcium Regulation, and Acute Glutamate Excitotoxicity in Cultured Cerebellar Granule Cells , 1996, Journal of neurochemistry.
[106] F. Fazekas,et al. Estrogen Replacement Therapy In Older Women: A Neuropsychological And Brain MRI Study , 1996, Journal of the American Geriatrics Society.
[107] I. Reynolds,et al. Mitochondrial Depolarization in Glutamate-Stimulated Neurons: An Early Signal Specific to Excitotoxin Exposure , 1996, The Journal of Neuroscience.
[108] S. Thayer,et al. Sequestration of glutamate-induced Ca2+ loads by mitochondria in cultured rat hippocampal neurons. , 1996, Journal of neurophysiology.
[109] Yaakov Stern,et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease , 1996, The Lancet.
[110] D. Selkoe,et al. Amyloid β-Protein and the Genetics of Alzheimer's Disease* , 1996, The Journal of Biological Chemistry.
[111] D. Dorsa,et al. Estrogen protects primary cortical neurons from glutamate toxicity , 1996, Neuroscience Letters.
[112] J. Gustafsson,et al. Cloning of a novel receptor expressed in rat prostate and ovary. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[113] A. Paganini-Hill. Oestrogen replacement therapy and Alzheimer's disease. , 1996, British journal of obstetrics and gynaecology.
[114] F. Holsboer,et al. 17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro. , 1995, Biochemical and biophysical research communications.
[115] J. Liehr,et al. Microsome-mediated 8-hydroxylation of guanine bases of DNA by steroid estrogens: correlation of DNA damage by free radicals with metabolic activation to quinones. , 1995, Carcinogenesis.
[116] J. C. Chisholm,et al. The Ca2+ influx induced by beta-amyloid peptide 25-35 in cultured hippocampal neurons results from network excitation. , 1995, Journal of neurobiology.
[117] B. Ames,et al. Oxidative damage and mitochondrial decay in aging. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[118] J. Woodgett,et al. Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation. , 1994, The Biochemical journal.
[119] J. Yesavage,et al. Estrogen Replacement Therapy and Memory in Older Women , 1994, Journal of the American Geriatrics Society.
[120] K. Gunter,et al. Mitochondrial calcium transport: physiological and pathological relevance. , 1994, The American journal of physiology.
[121] B. Sherwin,et al. Estrogen Use and Verbal Memory in Healthy Postmenopausal Women , 1994, Obstetrics and gynecology.
[122] B. Ames,et al. Oxidants, antioxidants, and the degenerative diseases of aging. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[123] J. Bockaert,et al. NMDA-dependent superoxide production and neurotoxicity , 1993, Nature.
[124] Charles Tator,et al. Cell-permeant Ca2+ chelators reduce early excitotoxic and ischemic neuronal injury in vitro and in vivo , 1993, Neuron.
[125] K. Imahori,et al. Glycogen synthase kinase 3β is identical to tau protein kinase I generating several epitopes of paired helical filaments , 1993 .
[126] D. Choi,et al. Glutamate receptor-induced 45Ca2+ accumulation in cortical cell culture correlates with subsequent neuronal degeneration , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[127] Mark P. Mattson,et al. Calcium as sculptor and destroyer of neural circuitry , 1992, Experimental Gerontology.
[128] M. Beal. Mechanisms of excitotoxicity in neurologic diseases , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[129] C. Cotman,et al. β-Amyloid neurotoxicity: A discussion of in vitro findings , 1992, Neurobiology of Aging.
[130] M. Mattson,et al. Glucose deprivation elicits neurofibrillary tangle-like antigenic changes in hippocampal neurons: Prevention by NGF and bFGF , 1992, Experimental Neurology.
[131] H. Strobel,et al. Catalysis of the oxidation of steroid and stilbene estrogens to estrogen quinone metabolites by the beta-naphthoflavone-inducible cytochrome P450 IA family. , 1992, Archives of biochemistry and biophysics.
[132] B. Mcewen,et al. Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat [published erratum appears in J Neurosci 1992 Oct;12(10):following table of contents] , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[133] J. Joseph. The putative role of free radicals in the loss of neuronal functioning in senescence , 1992, Integrative physiological and behavioral science : the official journal of the Pavlovian Society.
[134] Samuel Thayer,et al. Glutamate-induced calcium transient triggers delayed calcium overload and neurotoxicity in rat hippocampal neurons , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[135] H. Sies. Role of reactive oxygen species in biological processes , 1991, Klinische Wochenschrift.
[136] A. Ferreira,et al. Estrogen-enhanced neurite growth: evidence for a selective induction of Tau and stable microtubules , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[137] M. Nakano,et al. Stopped-flow investigation of antioxidant activity of estrogens in solution. , 1990, Biochimica et biophysica acta.
[138] R. Black,et al. Induction of Alzheimer antigens by an uncoupler of oxidative phosphorylation. , 1990, Archives of neurology.
[139] D. Roy,et al. The O-methylation of 4-hydroxyestradiol is inhibited by 2-hydroxyestradiol: implications for estrogen-induced carcinogenesis. , 1990, Carcinogenesis.
[140] A. Young,et al. Excitatory amino acids and Alzheimer's disease , 1989, Neurobiology of Aging.
[141] M. Dempsey,et al. Cyclosporin A is a potent inhibitor of the inner membrane permeability transition in liver mitochondria. , 1989, The Journal of biological chemistry.
[142] J. Weisz,et al. Monooxygenase mediating catecholestrogen formation by rat anterior pituitary is an estrogen-4-hydroxylase. , 1989, Endocrinology.
[143] M. Nakano,et al. Mechanism of O2- generation in reduction and oxidation cycle of ubiquinones in a model of mitochondrial electron transport systems. , 1988, Biochimica et biophysica acta.
[144] D. Choi,et al. N-methyl-D-aspartate receptors mediate hypoxic neuronal injury in cortical culture. , 1987, The Journal of pharmacology and experimental therapeutics.
[145] E. Niki,et al. Novel and potent biological antioxidants on membrane phospholipid peroxidation: 2-hydroxy estrone and 2-hydroxy estradiol. , 1987, Biochemical and biophysical research communications.
[146] D. Choi. Ionic dependence of glutamate neurotoxicity , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[147] H. Wiśniewski,et al. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[148] J. Olney,et al. Glutamate and the pathophysiology of hypoxic–ischemic brain damage , 1986, Annals of neurology.
[149] F. Naftolin,et al. Anovulation in female rats induced by neonatal administration of the catechol estrogens, 2-hydroxy-estradiol and 4-hydroxy-estradiol. , 1983, Neuroendocrinology.
[150] F. Naftolin,et al. The effects of oestrogen on hypothalamic tissue. , 1978, Ciba Foundation symposium.
[151] H Breuer,et al. Interactions between estrogens and catechol amines. 3. Studies on the methylation of catechol estrogens, catechol amines and other catechols by the ctechol-O-methyltransferases of human liver. , 1972, The Journal of clinical endocrinology and metabolism.
[152] S. Goldstein,et al. Binding of calcium by liver mitochondria of rats treated with steroid hormones. , 1966, The Journal of biological chemistry.
[153] Meharvan Singh. Ovarian hormones elicit phosphorylation of akt and extracellular-signal regulated kinase in explants of the cerebral cortex , 2007, Endocrine.
[154] C. Christiansen,et al. Early postmenopausal hormone therapy may prevent cognitive impairment later in life , 2005, Menopause.
[155] B. McEwen. Estrogen actions throughout the brain. , 2002, Recent progress in hormone research.
[156] D. Selkoe. Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. , 2001, Journal of Alzheimer's disease : JAD.
[157] T. Arendt,et al. Reversible in vivo phosphorylation of tau induced by okadaic acid and by unspecific brain lesion in rat. , 1998, Journal fur Hirnforschung.
[158] H. Schipper. Gomori‐positive astrocytes: Biological properties and implications for neurologic and neuroendocrine disorders , 1991, Glia.
[159] J. Liehr,et al. Free radical generation by redox cycling of estrogens. , 1990, Free radical biology & medicine.
[160] C. Léránth,et al. The cellular effects of estrogens on neuroendocrine tissues. , 1988, Journal of steroid biochemistry.
[161] J. Cabezas,et al. Effects of oestradiol, testosterone and medroxyprogesterone on subcellular fraction marker enzyme activities from rat liver and brain. , 1985, Comparative biochemistry and physiology. B, Comparative biochemistry.